Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Baggott

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
The Biochemical Journal|June 15, 1994
Differences in methotrexate and 7-hydroxymethotrexate inhibition of folate-dependent enzymes of purine nucleotide biosynthesisJ E Baggott, S L Morgan, W H Vaughn
The Biochemical Journal|May 15, 1986
Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotideJ E Baggott, W H Vaughn, B B Hudson
Biochimica Et Biophysica Acta|June 20, 1997
Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsinM A Niemann, J E Baggott, E J Miller
The Biochemical Journal|February 15, 2001
Bioactivity of [6R]-5-formyltetrahydrofolate, an unusual isomer, in humans and Enterococcus hirae, and cytochrome c oxidation of 10-formytetrahydrofolate to 10-formyldihydrofolateJ E Baggott, C B Robinson, K E Johnston
Journal of Cellular Biochemistry|September 1, 1997
Binding of SPAAT, the 44-residue C-terminal peptide of alpha 1-antitrypsin, to proteins of the extracellular matrixM A Niemann, J E Baggott, E J Miller
Arthritis and Rheumatism|November 18, 2000
Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and othersV Strand, S L Morgan, J E Baggott, et al.
Archives of Dermatology|July 20, 1999
Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasisJ E Baggott, S L Morgan, W M Sams, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexateS L Morgan, J E Baggott, H Refsum, et al.
The Journal of Rheumatology|March 28, 1998
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease preventionS L Morgan, J E Baggott, J Y Lee, et al.
The American Journal of Clinical Nutrition|August 1, 1987
Folate conjugase activity in the plasma and tumors of breast-cancer patientsJ E Baggott, D C Heimburger, C L Krumdieck, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
The Biochemical Journal|June 15, 1994
Differences in methotrexate and 7-hydroxymethotrexate inhibition of folate-dependent enzymes of purine nucleotide biosynthesisJ E Baggott, S L Morgan, W H Vaughn
The Biochemical Journal|May 15, 1986
Inhibition of 5-aminoimidazole-4-carboxamide ribotide transformylase, adenosine deaminase and 5'-adenylate deaminase by polyglutamates of methotrexate and oxidized folates and by 5-aminoimidazole-4-carboxamide riboside and ribotideJ E Baggott, W H Vaughn, B B Hudson
Biochimica Et Biophysica Acta|June 20, 1997
Inhibition of human serine proteases by SPAAT, the C-terminal 44-residue peptide from alpha1-antitrypsinM A Niemann, J E Baggott, E J Miller
The Biochemical Journal|February 15, 2001
Bioactivity of [6R]-5-formyltetrahydrofolate, an unusual isomer, in humans and Enterococcus hirae, and cytochrome c oxidation of 10-formytetrahydrofolate to 10-formyldihydrofolateJ E Baggott, C B Robinson, K E Johnston
Journal of Cellular Biochemistry|September 1, 1997
Binding of SPAAT, the 44-residue C-terminal peptide of alpha 1-antitrypsin, to proteins of the extracellular matrixM A Niemann, J E Baggott, E J Miller
Arthritis and Rheumatism|November 18, 2000
Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and othersV Strand, S L Morgan, J E Baggott, et al.
Archives of Dermatology|July 20, 1999
Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasisJ E Baggott, S L Morgan, W M Sams, et al.
Clinical Pharmacology and Therapeutics|November 1, 1991
Homocysteine levels in patients with rheumatoid arthritis treated with low-dose methotrexateS L Morgan, J E Baggott, H Refsum, et al.
The Journal of Rheumatology|March 28, 1998
Folic acid supplementation prevents deficient blood folate levels and hyperhomocysteinemia during longterm, low dose methotrexate therapy for rheumatoid arthritis: implications for cardiovascular disease preventionS L Morgan, J E Baggott, J Y Lee, et al.
The American Journal of Clinical Nutrition|August 1, 1987
Folate conjugase activity in the plasma and tumors of breast-cancer patientsJ E Baggott, D C Heimburger, C L Krumdieck, et al.
Pageof 5